Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.29 | -20.30 |
PEG Ratio (TTM) | -0.01 | -5.71 |
P/S Ratio (TTM) | 1.28 | 50.88 |
P/B Ratio (TTM) | 0.66 | 29.28 |
P/FCF Ratio (TTM) | -0.57 | -8.95 |
Price to 5YR AVG Earnings Ratio | -0.06 | -6.52 |
Price to 5YR AVG FCF Ratio | -1.96 | -14.78 |
Profitability (25%) |
Company | Industry |
---|---|---|
ROA (TTM) | -151.38% | -18.85% |
ROE (TTM) | -289.05% | 25.35% |
Net Profit Margin (TTM) | -153.21% | -827.80% |
ROIC 5YR AVG | 436.03% | -26.10% |
Growth (30%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -141.64% | 42.96% | -37.51% |
Revenue | -25.00% | -33.33% | -20.00% |
Net Income | -1.94% | 16.40% | -70.72% |
Cash Flow | 14.32% | 9.00% | -148.70% |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.10 | 6.09 |
Quick Ratio (TTM) | 3.10 | 5.87 |
D/E Ratio (TTM) | N/A | 1.00 |
Interest Coverage (TTM) | N/A | -9.57 |
Piotroski F-Score | 5 | 4 |
Altman Z-Score | N/A | 13.84 |
LTL to 5YR AVG FCF | N/A | 0.07 |
Shares Outstanding Growth 5YR AVG | 2,587.80% | 44.11% |